Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 167(1): 532-41, 2001 Jul 01.
Article in English | MEDLINE | ID: mdl-11418692

ABSTRACT

Blockade of the CD40-CD154 pathway can inhibit CD4(+) T cell activation but is unable to prevent immune responses mediated by CD8(+) T cells. However, even in the absence of CD8(+) T cells, inhibition of the CD40-CD154 pathway is insufficient to prevent the development of transplant arteriosclerosis. This study investigated the mechanisms of transplant arteriosclerosis in the absence of the CD40 pathway. C57BL/6 CD40(-/-) (H2(b)) recipients were transplanted with MHC-mismatched BALB/c (H2(d)) aortas. Transplant arteriosclerosis was evident in both CD40(-/-) and CD40(+/-) mice (intimal proliferation was 59 +/- 5% for CD40(-/-) mice vs 58 +/- 4% for CD40(+/-) mice) in the presence or absence of CD8(+) T cells (intimal proliferation was 46 +/- 7% for CD40(-/-) anti-CD8-treated mice vs 50 +/- 10% for CD40(+/-) anti-CD8-treated mice), confirming that CD8(+) T cells are not essential effector cells for the development of this disease. In CD40(-/-) recipients depleted of CD8(+) T cells, the number of eosinophils infiltrating the graft was markedly increased (109 +/- 24 eosinophils/grid for CD40(-/-) anti-CD8-treated mice vs 28 +/- 7 for CD40(+/-) anti-CD8-treated mice). The increased presence of eosinophils correlated with augmented intragraft production of IL-4. To test the hypothesis that IL-4 was responsible for the intimal proliferation, CD8 T cell-depleted CD40(-/-) recipients were treated with anti-IL-4 mAb. This resulted in significantly reduced eosinophil infiltration into the graft (12 +/- 5 eosinophils/grid for CD40(-/-) anti-CD8(+), anti-IL-4-treated mice vs 109 +/- 24 for CD40(-/-) anti-CD8-treated mice), intragraft eotaxin, CCR3 mRNA production, and the level of intimal proliferation (18 +/- 5% for CD40(-/-) anti-CD8(+)-, anti-IL-4-treated mice vs 46 +/- 7% for CD40(-/-) anti-CD8-treated mice). In conclusion, elevated intragraft IL-4 production results in an eosinophil infiltrate and is an important mechanism for CD8(+) T cell-independent transplant arteriosclerosis in the absence of CD40-CD154 costimulation.


Subject(s)
Aorta, Thoracic/transplantation , Arteriosclerosis/immunology , CD40 Antigens/genetics , CD40 Ligand/genetics , Chemokines, CC , Interleukin-4/physiology , Animals , Antibodies, Monoclonal/administration & dosage , Antigen-Presenting Cells/immunology , Antigen-Presenting Cells/metabolism , Arteriosclerosis/genetics , Arteriosclerosis/pathology , Arteriosclerosis/prevention & control , CD4-Positive T-Lymphocytes/pathology , CD40 Antigens/biosynthesis , CD40 Antigens/physiology , CD40 Ligand/physiology , CD8-Positive T-Lymphocytes/pathology , Cell Movement/genetics , Cell Movement/immunology , Chemokine CCL11 , Cytokines/biosynthesis , Cytokines/genetics , Eosinophils/pathology , H-2 Antigens/immunology , Histocompatibility Antigen H-2D , Interferon-gamma/antagonists & inhibitors , Interferon-gamma/genetics , Interleukin-4/antagonists & inhibitors , Interleukin-4/genetics , Interleukin-4/immunology , Isoantibodies/biosynthesis , Lymphocyte Depletion , Macrophage-1 Antigen/biosynthesis , Macrophages/immunology , Macrophages/pathology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , RNA, Messenger/antagonists & inhibitors , RNA, Messenger/biosynthesis , Receptors, CCR3 , Receptors, Chemokine/biosynthesis , Receptors, Chemokine/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...